STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022		41,025,062
Beginning balance at Dec. 31, 2022	$ 188,775	$ 4	$ 359,949	$ (170,427)	$ (751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of issuance costs (in shares)		16,774,193
Issuance of common stock for cash, net of issuance costs	121,904	$ 2	121,902
Stock options exercised for cash (in shares)		111,206
Stock options exercised for cash	325		325
Issuance of warrant with Term Loan	1,132		1,132
Unrealized gain (loss) on marketable securities	1,063				1,063
Stock-based compensation	6,145		6,145
Net loss	$ (52,371)			(52,371)
Ending balance (in shares) at Dec. 31, 2023	57,910,461	57,910,461
Ending balance at Dec. 31, 2023	$ 266,973	$ 6	489,453	(222,798)	312
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of issuance costs (in shares)		2,068,246
Issuance of common stock for cash, net of issuance costs	7,938		7,938
Issuance of common stock for restricted stock units, net of shares withheld for taxes (in shares)		115,376
Issuance of common stock for restricted stock units, net of shares withheld for taxes	$ (41)		(41)
Stock options exercised for cash (in shares)	0
Unrealized gain (loss) on marketable securities	$ (360)				(360)
Stock-based compensation	9,635		9,635
Net loss	$ (102,329)			(102,329)
Ending balance (in shares) at Dec. 31, 2024	60,094,083	60,094,083
Ending balance at Dec. 31, 2024	$ 181,816	$ 6	$ 506,985	$ (325,127)	$ (48)